Cme (CME) Cost of Revenue (2009 - 2026)

Cme (CME) has 18 years of Cost of Revenue data on file, last reported at $52.5 million in Q1 2026.

• Quarterly Cost of Revenue fell 3.31% year-over-year to $52.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (down 7.01% YoY) and the FY2025 annual result came in at $248.5 million, down 7.14% from the prior year.
• Cost of Revenue slipped to $52.5 million in Q1 2026 per CME's latest filing, from $85.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $101.9 million in Q4 2023 and bottomed at $43.9 million in Q3 2022.
• The 5-year median for Cost of Revenue is $56.6 million (2024), against an average of $63.9 million.
• The widest annual swing landed in 2023, when Cost of Revenue increased 28.7%; it then declined 11.56% in 2025.
• Tracing CME's Cost of Revenue over 5 years: stood at $95.0 million in 2022, then advanced by 7.26% to $101.9 million in 2023, then slipped by 11.29% to $90.4 million in 2024, then slipped by 4.98% to $85.9 million in 2025, then slumped by 38.88% to $52.5 million in 2026.
• Per Business Quant, the three latest CME Cost of Revenue figures stand at $52.5 million (Q1 2026), $85.9 million (Q4 2025), and $55.1 million (Q3 2025).

Peer Comparison